Stay updated on RO6958688 in CEA+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the RO6958688 in CEA+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RO6958688 in CEA+ Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A 2024 *Nature Communications* article reporting results from two Phase 1 trials of the CEA-CD3 bispecific antibody cibisatamab, with or without atezolizumab, was added to the study’s publication list.
    Difference
    0.1%
    Check dated 2026-11-18T03:24:18.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The record now presents details for the completed Phase 1 RO6958688 study, including its design, eligibility criteria, study locations, interventions, and outcome measures. Study registration dates and related publications are also displayed.
    Difference
    61%
    Check dated 2026-11-11T02:18:33.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-04T01:12:42.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A general NIH announcement about terminology changes appears above the 403 error message. The site revision label also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:08:42.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T01:11:09.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The study page is now a 403 Forbidden error page, replacing the usual study details with a simple error view. This indicates restricted access to the study information and navigation options on the page.
    Difference
    19%
    Check dated 2026-09-23T01:15:21.000Z thumbnail image

Stay in the know with updates to RO6958688 in CEA+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RO6958688 in CEA+ Solid Tumors Clinical Trial page.